BOOK
Quality of Life Issues in Dermatology, An Issue of Dermatologic Clinics - E-Book
(2012)
Additional Information
Book Details
Abstract
This issue defines the concepts and outlines the concerns surrounding quality of life issues in dermatology. Articles review the concepts of general versus disease-specific measures and include Patient Preference QOL Measures, and Review of Children and Family QOL Measures. Disease specific QOL topics are also included, such as Melanoma, Acne, and Eczema.
Table of Contents
| Section Title | Page | Action | Price |
|---|---|---|---|
| Front Cover | Cover | ||
| Dermatologic Clinics | i | ||
| Copyright Page | ii | ||
| Table of Contents | vii | ||
| Contributors | iii | ||
| Dermatologic Clinics | xi | ||
| Preface | xiii | ||
| Chapter 1. Health-Related Quality of Life in Dermatology: Introduction and Overview | 205 | ||
| RECOMMENDATIONS FROM THE INTERNATIONAL DERMATOEPIDEMIOLOGY ASSOCIATION MEETING | 205 | ||
| OVERVIEW OF COMPENDIUM | 207 | ||
| SUMMARY | 208 | ||
| ACKNOWLEDGMENTS | 208 | ||
| REFERENCES | 208 | ||
| Chapter 2. Overview of Health Status Quality-of-Life Measures | 209 | ||
| CONSIDERATIONS IN SELECTING A HEALTH STATUS QOL INSTRUMENT | 210 | ||
| GENERIC HEALTH STATUS QOL MEASURES | 211 | ||
| DERMATOLOGY-SPECIFIC INSTRUMENTS | 213 | ||
| CONDITION-SPECIFIC MEASURES | 214 | ||
| USES FOR HEALTH STATUS QOL MEASURES IN DERMATOLOGY | 217 | ||
| SUMMARY | 218 | ||
| REFERENCES | 218 | ||
| Chapter 3. Preference-Based Measures in Dermatology: An Overview of Utilities and Willingness to Pay | 223 | ||
| UTILITIES: DEFINITIONS AND METHODS | 223 | ||
| WILLINGNESS TO PAY: DEFINITIONS AND METHODS | 225 | ||
| APPLICATIONS OF UTILITIES AND WTP | 225 | ||
| UTILITIES IN DERMATOLOGY | 226 | ||
| WTP IN DERMATOLOGY | 226 | ||
| DIFFERENCES BETWEEN UTILITIES AND WTP | 227 | ||
| WTP AND TIME TRADE-OFF UTILITY CORRELATION IN DERMATOLOGY | 228 | ||
| SUMMARY | 228 | ||
| REFERENCES | 229 | ||
| Chapter 4. The Skindex Instruments to Measure the Effects of Skin Disease on Quality of Life | 231 | ||
| DEVELOPMENT OF SKINDEX | 231 | ||
| CHOOSING BETWEEN SKINDEX-29 AND SKINDEX-16 | 233 | ||
| INTERPRETATION OF SCORES | 233 | ||
| USING SKINDEX IN RESEARCH STUDIES AND IN CLINIC | 234 | ||
| FUTURE DIRECTIONS | 235 | ||
| SUMMARY | 235 | ||
| REFERENCES | 235 | ||
| Chapter 5. A Review of the Use of the Dermatology Life Quality Index as a Criterion in Clinical Guidelines and Health Technology Assessments in Psoriasis and Chronic Hand Eczema | 237 | ||
| LITERATURE SEARCH STRATEGY | 238 | ||
| CLINICAL USE OF THE DLQI IN PSORIASIS | 238 | ||
| CLINICAL USE OF THE DLQI IN CHE | 240 | ||
| HEALTH ECONOMIC USE OF DLQI IN HEALTH TECHNOLOGY APPRAISAL OF NEW DERMATOLOGY TREATMENTS | 240 | ||
| DISCUSSION | 241 | ||
| SUMMARY | 242 | ||
| ACKNOWLEDGMENTS | 242 | ||
| REFERENCES | 242 | ||
| Chapter 6. Health-Related Quality of Life in Patients with Melanoma: Overview of Instruments and Outcomes | 245 | ||
| QOL INSTRUMENTS | 246 | ||
| METHODS | 248 | ||
| MELANOMA-SPECIFIC FINDINGS | 248 | ||
| SUMMARY | 250 | ||
| ACKNOWLEDGMENTS | 251 | ||
| REFERENCES | 251 | ||
| Chapter 7. Quality-of-Life Issuesin Vitiligo | 255 | ||
| EPIDEMIOLOGY | 255 | ||
| SKIN TYPE | 255 | ||
| AGE | 256 | ||
| MARITAL STATUS | 256 | ||
| LOCATION OF VITILIGO: EXPOSED VERSUS UNEXPOSED | 257 | ||
| GENDER | 257 | ||
| CURRENT TOOLS FOR MEASUREMENT OF QoL IN VITILIGO | 258 | ||
| IMPACT ON HRQL AFTER TREATMENT | 264 | ||
| NONMEDICAL INTERVENTIONS | 265 | ||
| COSMETIC CAMOUFLAGE | 265 | ||
| SURGICAL INTERVENTIONS | 265 | ||
| SUMMARY | 266 | ||
| REFERENCES | 266 | ||
| Chapter 8. Melasma Quality of Life Measures | 269 | ||
| MELASMA | 269 | ||
| QOL INSTRUMENTS | 270 | ||
| MELASQOL | 270 | ||
| MELASMA IN LATINO MEN | 272 | ||
| SPANISH MELASQOL | 273 | ||
| TRANSLATION ISSUES | 274 | ||
| BRAZILIAN PORTUGUESE MELASQOL | 274 | ||
| FRENCH MELASQOL | 276 | ||
| TURKISH MELASQOL | 277 | ||
| SUMMARY | 279 | ||
| REFERENCES | 279 | ||
| Chapter 9. Quality-of-LifeInstruments: Evaluation of the Impact of Psoriasison Patients | 281 | ||
| DEFINITION OF QoL | 282 | ||
| IMPORTANCE OF QoL EVALUATION | 282 | ||
| HEALTH-RELATED QoL INSTRUMENTS | 282 | ||
| QoL INSTRUMENTS FOR PSORIASIS | 282 | ||
| GENERIC QoL INSTRUMENTS | 283 | ||
| DERMATOLOGY-SPECIFIC QoL INSTRUMENTS | 284 | ||
| DERMATOLOGY-SPECIFIC QoL INSTRUMENTS: CHILDREN | 285 | ||
| PSORIASIS-SPECIFIC QoL INSTRUMENTS | 286 | ||
| SUMMARY | 289 | ||
| REFERENCES | 289 | ||
| Chapter 10. Quality of Life Measures for Acne Patients | 293 | ||
| METHODS | 294 | ||
| RESULTS | 294 | ||
| DISCUSSION | 296 | ||
| SUMMARY | 298 | ||
| REFERENCES | 299 | ||
| Chapter 11. Quality-of-Life Measurement in Blistering Diseases | 301 | ||
| INHERITED BLISTERING DISEASES | 302 | ||
| AUTOIMMUNE BLISTERING DISEASE | 304 | ||
| SUMMARY | 306 | ||
| ACKNOWLEDGMENTS | 306 | ||
| REFERENCES | 306 | ||
| Chapter 12. Pruritus | 309 | ||
| METHODS | 310 | ||
| RESULTS | 310 | ||
| SUMMARY | 320 | ||
| REFERENCES | 320 | ||
| Chapter 13. Health-Related Quality-of-Life Assessment in Dermatologic Practice: Relevance and Application | 323 | ||
| HRQoL ASSESSMENT IN DERMATOLOGY: WHY? | 324 | ||
| HRQoL ASSESSMENT IN DERMATOLOGY: HOW? | 326 | ||
| SUMMARY | 330 | ||
| ACKNOWLEDGMENTS | 331 | ||
| REFERENCES | 331 | ||
| Chapter 14. Clinical Meaning in Skin-specific Quality of Life Instruments: A Comparison of the Dermatology Life Quality Index and Skindex Banding Systems | 333 | ||
| DERMATOLOGY LIFE QUALITY INDEX | 334 | ||
| SKINDEX | 334 | ||
| CLINICAL MEANING ASSIGNED TO SCORE | 335 | ||
| SKINDEX VERSUS DLQI | 336 | ||
| REFERENCES | 340 | ||
| Chapter 15. Future Directions in Dermatology Qualityof Life Measures | 343 | ||
| CLINICAL SIGNIFICANCE OF QoL MEASURES | 344 | ||
| INTERPRETING RESULTS FROMOUTCOMES DATA | 344 | ||
| CHOOSING MEASURES: GUIDELINES WHENDISEASE-SPECIFIC MEASURES DO NOT EXIST | 345 | ||
| PREFERENCE-BASED MEASURES | 346 | ||
| FUTURE DIRECTIONS FOR OUTCOMES RESEARCH | 347 | ||
| REFERENCES | 347 | ||
| Index | 349 |